APO Research
Talk to an analyst

APO RESEARCH · REPORT

Argatroban

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Selected research

Industry Growth & Trends

Global Argatroban Industry Growth and Trends Forecast to 2032

20 December 202590 pages

Choose your research edition.

Industry ResearchArgatroban Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Argatroban Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Argatroban Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Argatroban Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Argatroban Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.

Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.

Read the full market overview

In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.

Report Scope

This report provides a structured, data-driven view of the global Argatroban market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Argatroban market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Argatroban market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Argatroban.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Argatroban market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Argatroban Market by Company

Pfizer, Inc

SANDOZ

GlaxoSmithKline Plc

fresenius-kabi

Eagle Pharmaceuticals, Inc

Mitsubishi Tanabe Pharma

Teva Pharmaceutical Industries Ltd

WEST-WARD,INC

Argatroban Segment by Type

Argatroban Powder

Argatroban Injection

Argatroban Segment by Application

Heparin-induced Thrombocytopenia (HIT)

Percutaneous Coronary Intervention

Cerebral Arterial Thrombosis

Argatroban Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Argatroban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Argatroban and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Argatroban.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Argatroban in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Argatroban Powder Table 2. Major Company of Argatroban Injection Table 3. Global Argatroban Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Argatroban Sales by Type (2021-2026) & (g) Table 5. Global Argatroban Sales Market Share in Volume by Type (2021-2026) Table 6. Global Argatroban Sales by Type (2021-2026) & (US$ Million) Table 7. Global Argatroban Sales Market Share in Value by Type (2021-2026) Table 8. Global Argatroban Price by Type (2021-2026) & (USD/g) Table 9. Global Argatroban Sales by Type (2027-2032) & (g) Table 10. Global Argatroban Sales Market Share in Volume by Type (2027-2032) Table 11. Global Argatroban Sales by Type (2027-2032) & (US$ Million) Table 12. Global Argatroban Sales Market Share in Value by Type (2027-2032) Table 13. Global Argatroban Price by Type (2027-2032) & (USD/g) Table 14. North America Argatroban Sales by Type (2021-2026) & (g) Table 15. North America Argatroban Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Argatroban Sales by Type (2021-2026) & (g) Table 17. Europe Argatroban Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Argatroban Sales by Type (2021-2026) & (g) Table 19. Asia-Pacific Argatroban Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Argatroban Sales by Type (2021-2026) & (g) Table 21. Latin America Argatroban Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Argatroban Sales by Type (2021-2026) & (g) Table 23. Middle East and Africa Argatroban Sales by Type (2021-2026) & (US$ Million) Table 24. Argatroban Industry Trends Table 25. Argatroban Industry Drivers Table 26. Argatroban Industry Opportunities and Challenges Table 27. Argatroban Industry Restraints Table 28. Global Argatroban Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Argatroban Revenue Market Share by Company (2021-2026) Table 30. Global Argatroban Sales by Company (2021-2026) & (g) Table 31. Global Argatroban Sales Share by Company (2021-2026) Table 32. Global Argatroban Market Price by Company (2021-2026) & (USD/g) Table 33. Global Argatroban Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Argatroban Major Company Production Sites and Headquarters Table 35. Global Argatroban Company, Product Type & Application Table 36. Global Argatroban Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Argatroban by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Argatroban Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Argatroban Sales by Region (2021-2026) & (g) Table 41. Global Argatroban Sales Market Share in Volume by Region (2021-2026) Table 42. Global Argatroban Sales by Region (2021-2026) & (US$ Million) Table 43. Global Argatroban Sales Market Share in Value by Region (2021-2026) Table 44. Global Argatroban Sales (g), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 45. Global Argatroban Sales by Region (2027-2032) & (g) Table 46. Global Argatroban Sales Market Share in Volume by Region (2027-2032) Table 47. Global Argatroban Sales by Region (2027-2032) & (US$ Million) Table 48. Global Argatroban Sales Market Share in Value by Region (2027-2032) Table 49. Global Argatroban Sales (g), Value (US$ Million), Price (USD/g) and Gross Margin (2027-2032) Table 50. Global Argatroban Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Argatroban Sales by Application (2021-2026) & (g) Table 52. Global Argatroban Sales Market Share in Volume by Application (2021-2026) Table 53. Global Argatroban Sales by Application (2021-2026) & (US$ Million) Table 54. Global Argatroban Sales Market Share in Value by Application (2021-2026) Table 55. Global Argatroban Price by Application (2021-2026) & (USD/g) Table 56. Global Argatroban Sales by Application (2027-2032) & (g) Table 57. Global Argatroban Sales Market Share in Volume by Application (2027-2032) Table 58. Global Argatroban Sales by Application (2027-2032) & (US$ Million) Table 59. Global Argatroban Sales Market Share in Value by Application (2027-2032) Table 60. Global Argatroban Price by Application (2027-2032) & (USD/g) Table 61. North America Argatroban Sales by Application (2021-2026) & (g) Table 62. North America Argatroban Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Argatroban Sales by Application (2021-2026) & (g) Table 64. Europe Argatroban Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Argatroban Sales by Application (2021-2026) & (g) Table 66. Asia-Pacific Argatroban Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Argatroban Sales by Application (2021-2026) & (g) Table 68. Latin America Argatroban Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Argatroban Sales by Application (2021-2026) & (g) Table 70. Middle East and Africa Argatroban Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer, Inc Company Information Table 72. Pfizer, Inc Business Overview Table 73. Pfizer, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 74. Pfizer, Inc Argatroban Product Portfolio Table 75. Pfizer, Inc Recent Development Table 76. SANDOZ Company Information Table 77. SANDOZ Business Overview Table 78. SANDOZ Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 79. SANDOZ Argatroban Product Portfolio Table 80. SANDOZ Recent Development Table 81. GlaxoSmithKline Plc Company Information Table 82. GlaxoSmithKline Plc Business Overview Table 83. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline Plc Argatroban Product Portfolio Table 85. GlaxoSmithKline Plc Recent Development Table 86. fresenius-kabi Company Information Table 87. fresenius-kabi Business Overview Table 88. fresenius-kabi Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 89. fresenius-kabi Argatroban Product Portfolio Table 90. fresenius-kabi Recent Development Table 91. Eagle Pharmaceuticals, Inc Company Information Table 92. Eagle Pharmaceuticals, Inc Business Overview Table 93. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 94. Eagle Pharmaceuticals, Inc Argatroban Product Portfolio Table 95. Eagle Pharmaceuticals, Inc Recent Development Table 96. Mitsubishi Tanabe Pharma Company Information Table 97. Mitsubishi Tanabe Pharma Business Overview Table 98. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 99. Mitsubishi Tanabe Pharma Argatroban Product Portfolio Table 100. Mitsubishi Tanabe Pharma Recent Development Table 101. Teva Pharmaceutical Industries Ltd Company Information Table 102. Teva Pharmaceutical Industries Ltd Business Overview Table 103. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 104. Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio Table 105. Teva Pharmaceutical Industries Ltd Recent Development Table 106. WEST-WARD,INC Company Information Table 107. WEST-WARD,INC Business Overview Table 108. WEST-WARD,INC Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 109. WEST-WARD,INC Argatroban Product Portfolio Table 110. WEST-WARD,INC Recent Development Table 111. North America Argatroban Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 112. North America Argatroban Sales by Country (2021-2026) & (g) Table 113. North America Argatroban Sales Market Share by Country (2021-2026) Table 114. North America Argatroban Sales Forecast by Country (2027-2032) & (g) Table 115. North America Argatroban Sales Market Share Forecast by Country (2027-2032) Table 116. North America Argatroban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Argatroban Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Argatroban Market Share by Country (2021-2026) Table 119. North America Argatroban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Argatroban Market Share Forecast by Country (2027-2032) Table 121. Europe Argatroban Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 122. Europe Argatroban Sales by Country (2021-2026) & (g) Table 123. Europe Argatroban Sales Market Share by Country (2021-2026) Table 124. Europe Argatroban Sales Forecast by Country (2027-2032) & (g) Table 125. Europe Argatroban Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Argatroban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Argatroban Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Argatroban Market Share by Country (2021-2026) Table 129. Europe Argatroban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Argatroban Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Argatroban Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Argatroban Sales by Country (2021-2026) & (g) Table 133. Asia-Pacific Argatroban Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Argatroban Sales Forecast by Country (2027-2032) & (g) Table 135. Asia-Pacific Argatroban Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Argatroban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Argatroban Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Argatroban Market Share by Country (2021-2026) Table 139. Asia-Pacific Argatroban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Argatroban Market Share Forecast by Country (2027-2032) Table 141. Latin America Argatroban Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 142. Latin America Argatroban Sales by Country (2021-2026) & (g) Table 143. Latin America Argatroban Sales Market Share by Country (2021-2026) Table 144. Latin America Argatroban Sales Forecast by Country (2027-2032) & (g) Table 145. Latin America Argatroban Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Argatroban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Argatroban Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Argatroban Market Share by Country (2021-2026) Table 149. Latin America Argatroban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Argatroban Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Argatroban Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Argatroban Sales by Country (2021-2026) & (g) Table 153. Middle East and Africa Argatroban Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Argatroban Sales Forecast by Country (2027-2032) & (g) Table 155. Middle East and Africa Argatroban Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Argatroban Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Argatroban Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Argatroban Market Share by Country (2021-2026) Table 159. Middle East and Africa Argatroban Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Argatroban Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Argatroban Distributors List Table 164. Argatroban Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Argatroban Image Figure 2. Global Argatroban Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Argatroban Market Size (2021-2032) & (US$ Million) Figure 4. Global Argatroban Sales (2021-2032) & (g) Figure 5. Argatroban Powder Image Figure 6. Global Argatroban Powder Sales YoY Growth (2021-2032) & (g) Figure 7. Argatroban Injection Image Figure 8. Global Argatroban Injection Sales YoY Growth (2021-2032) & (g) Figure 9. Global Argatroban Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Argatroban Market Share by Type 2025 VS 2032 Figure 11. North America Argatroban Sales Market Share in Volume by Type in 2025 Figure 12. North America Argatroban Sales Market Share in Value by Type in 2025 Figure 13. Europe Argatroban Sales Market Share in Volume by Type in 2025 Figure 14. Europe Argatroban Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Argatroban Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Argatroban Sales Market Share in Value by Type in 2025 Figure 17. Latin America Argatroban Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Argatroban Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Argatroban Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Argatroban Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Argatroban Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Heparin-induced Thrombocytopenia (HIT) Image Figure 24. Global Heparin-induced Thrombocytopenia (HIT) Sales YoY Growth (2021-2032) & (g) Figure 25. Percutaneous Coronary Intervention Image Figure 26. Global Percutaneous Coronary Intervention Sales YoY Growth (2021-2032) & (g) Figure 27. Cerebral Arterial Thrombosis Image Figure 28. Global Cerebral Arterial Thrombosis Sales YoY Growth (2021-2032) & (g) Figure 29. Global Argatroban Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Argatroban Market Share by Application 2025 VS 2032 Figure 31. North America Argatroban Sales Market Share in Volume by Application in 2025 Figure 32. North America Argatroban Sales Market Share in Value by Application in 2025 Figure 33. Europe Argatroban Sales Market Share in Volume by Application in 2025 Figure 34. Europe Argatroban Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Argatroban Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Argatroban Sales Market Share in Value by Application in 2025 Figure 37. Latin America Argatroban Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Argatroban Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Argatroban Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Argatroban Sales Market Share in Value by Application in 2025 Figure 41. North America Argatroban Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 42. North America Argatroban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Argatroban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Argatroban Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Argatroban Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 46. Europe Argatroban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Argatroban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Argatroban Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Argatroban Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 50. Asia-Pacific Argatroban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Argatroban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Argatroban Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Argatroban Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 54. Latin America Argatroban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Argatroban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Argatroban Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Argatroban Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 58. Middle East and Africa Argatroban Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Argatroban Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Argatroban Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Argatroban Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Argatroban Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Argatroban Powder
  • Argatroban Injection
Applications
  • Heparin-induced Thrombocytopenia (HIT)
  • Percutaneous Coronary Intervention
  • Cerebral Arterial Thrombosis
Companies covered
  • Pfizer, Inc
  • SANDOZ
  • GlaxoSmithKline Plc
  • fresenius-kabi
  • Eagle Pharmaceuticals, Inc
  • Mitsubishi Tanabe Pharma
  • Teva Pharmaceutical Industries Ltd
  • WEST-WARD,INC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Argatroban Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Argatroban Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Argatroban Market by Type
  6. 1.3.1 Argatroban Powder
  7. 1.3.2 Argatroban Injection
  8. 1.4 Global Argatroban Market Size by Type
  9. 1.4.1 Global Argatroban Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Argatroban Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Argatroban Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Argatroban Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Argatroban Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Argatroban Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Argatroban Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Argatroban Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Argatroban Industry Trends
  2. 2.2 Argatroban Industry Drivers
  3. 2.3 Argatroban Industry Opportunities and Challenges
  4. 2.4 Argatroban Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Argatroban Revenue (2021-2026)
  2. 3.2 Global Top Players by Argatroban Sales (2021-2026)
  3. 3.3 Global Top Players by Argatroban Price (2021-2026)
  4. 3.4 Global Argatroban Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Argatroban Major Company Production Sites & Headquarters
  6. 3.6 Global Argatroban Company, Product Type & Application
  7. 3.7 Global Argatroban Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Argatroban Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Argatroban Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Argatroban Tier 1, Tier 2, and Tier 3
4 Argatroban Regional Status and Outlook
  1. 4.1 Global Argatroban Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Argatroban Historic Market Size by Region
  3. 4.2.1 Global Argatroban Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Argatroban Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Argatroban Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Argatroban Forecasted Market Size by Region
  7. 4.3.1 Global Argatroban Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Argatroban Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Argatroban Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Argatroban by Application
  1. 5.1 Argatroban Market by Application
  2. 5.1.1 Heparin-induced Thrombocytopenia (HIT)
  3. 5.1.2 Percutaneous Coronary Intervention
  4. 5.1.3 Cerebral Arterial Thrombosis
  5. 5.2 Global Argatroban Market Size by Application
  6. 5.2.1 Global Argatroban Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Argatroban Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Argatroban Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Argatroban Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Argatroban Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Argatroban Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Argatroban Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Argatroban Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer, Inc
  2. 6.1.1 Pfizer, Inc Company Information
  3. 6.1.2 Pfizer, Inc Business Overview
  4. 6.1.3 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer, Inc Argatroban Product Portfolio
  6. 6.1.5 Pfizer, Inc Recent Developments
  7. 6.2 SANDOZ
  8. 6.2.1 SANDOZ Company Information
  9. 6.2.2 SANDOZ Business Overview
  10. 6.2.3 SANDOZ Argatroban Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SANDOZ Argatroban Product Portfolio
  12. 6.2.5 SANDOZ Recent Developments
  13. 6.3 GlaxoSmithKline Plc
  14. 6.3.1 GlaxoSmithKline Plc Company Information
  15. 6.3.2 GlaxoSmithKline Plc Business Overview
  16. 6.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxoSmithKline Plc Argatroban Product Portfolio
  18. 6.3.5 GlaxoSmithKline Plc Recent Developments
  19. 6.4 fresenius-kabi
  20. 6.4.1 fresenius-kabi Company Information
  21. 6.4.2 fresenius-kabi Business Overview
  22. 6.4.3 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 fresenius-kabi Argatroban Product Portfolio
  24. 6.4.5 fresenius-kabi Recent Developments
  25. 6.5 Eagle Pharmaceuticals, Inc
  26. 6.5.1 Eagle Pharmaceuticals, Inc Company Information
  27. 6.5.2 Eagle Pharmaceuticals, Inc Business Overview
  28. 6.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eagle Pharmaceuticals, Inc Argatroban Product Portfolio
  30. 6.5.5 Eagle Pharmaceuticals, Inc Recent Developments
  31. 6.6 Mitsubishi Tanabe Pharma
  32. 6.6.1 Mitsubishi Tanabe Pharma Company Information
  33. 6.6.2 Mitsubishi Tanabe Pharma Business Overview
  34. 6.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mitsubishi Tanabe Pharma Argatroban Product Portfolio
  36. 6.6.5 Mitsubishi Tanabe Pharma Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd
  38. 6.7.1 Teva Pharmaceutical Industries Ltd Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
  43. 6.8 WEST-WARD,INC
  44. 6.8.1 WEST-WARD,INC Company Information
  45. 6.8.2 WEST-WARD,INC Business Overview
  46. 6.8.3 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 WEST-WARD,INC Argatroban Product Portfolio
  48. 6.8.5 WEST-WARD,INC Recent Developments
7 North America by Country
  1. 7.1 North America Argatroban Sales by Country
  2. 7.1.1 North America Argatroban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Argatroban Sales by Country (2021-2026)
  4. 7.1.3 North America Argatroban Sales Forecast by Country (2027-2032)
  5. 7.2 North America Argatroban Market Size by Country
  6. 7.2.1 North America Argatroban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Argatroban Market Size by Country (2021-2026)
  8. 7.2.3 North America Argatroban Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Argatroban Sales by Country
  2. 8.1.1 Europe Argatroban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Argatroban Sales by Country (2021-2026)
  4. 8.1.3 Europe Argatroban Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Argatroban Market Size by Country
  6. 8.2.1 Europe Argatroban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Argatroban Market Size by Country (2021-2026)
  8. 8.2.3 Europe Argatroban Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Argatroban Sales by Country
  2. 9.1.1 Asia-Pacific Argatroban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Argatroban Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Argatroban Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Argatroban Market Size by Country
  6. 9.2.1 Asia-Pacific Argatroban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Argatroban Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Argatroban Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Argatroban Sales by Country
  2. 10.1.1 South America Argatroban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Argatroban Sales by Country (2021-2026)
  4. 10.1.3 South America Argatroban Sales Forecast by Country (2027-2032)
  5. 10.2 South America Argatroban Market Size by Country
  6. 10.2.1 South America Argatroban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Argatroban Market Size by Country (2021-2026)
  8. 10.2.3 South America Argatroban Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Argatroban Sales by Country
  2. 11.1.1 Middle East and Africa Argatroban Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Argatroban Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Argatroban Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Argatroban Market Size by Country
  6. 11.2.1 Middle East and Africa Argatroban Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Argatroban Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Argatroban Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Argatroban Value Chain Analysis
  2. 12.1.1 Argatroban Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Argatroban Production Mode & Process
  7. 12.2 Argatroban Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Argatroban Distributors
  10. 12.2.3 Argatroban Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst